openPR Logo
Press release

Oncology Drugs Market is growth 2019 | Novartis International AG, Celgene Corporation, Johnson & Johnson, Bristol-Myers Squibb, Pfizer Inc., Merck & Co., Eli Lilly and Company, AbbVie, Inc

09-25-2019 03:20 PM CET | Health & Medicine

Press release from: CMI Research

Oncology Drugs Market

Oncology Drugs Market

Oncology Drugs

High cost of cancer drugs and adoption of alternative treatment options such as surgery and radiation therapy are major factors hindering the oncology drugs market growth. Several blockbuster oncology drugs in the market are expected to lose patent during 2018-2020, which is turn acts as an opportunities for emerging players in the global oncology drugs market.

Cancer is one of the deadliest disease with less chance of survival as the disease progresses. International Agency for Research on Cancer published GLOBOCAN 2018 report, which estimates cancer incidence and mortality rate. This report focus on geographic variability of cancer incidence rate and mortality rate across 20 world regions. This report projected 18.1 million new cancer cases (17.0 million excluding nonmelanoma skin cancer) and 9.6 million cancer deaths (9.5 million excluding nonmelanoma skin cancer) in 2018. Therefore, high prevalence of cancer is expected to be major factor for growth of the global oncology drugs market.

Request Sample of This Report: www.coherentmarketinsights.com/insight/request-sample/2332

According to a report by Pharmaceutical Research and Manufacturers Association in 2015, over 800 drugs are in development stage targeting various types of cancer. Moreover, same source suggested that around 73% of personalized medicine under development are targeted towards cancer.

Melanoma, colorectal cancer, blood cancer, breast cancer, lung cancer, and prostate cancer are the most targeted cancer for drug development. According to International Federation of the Pharmaceutical Manufacturers Association’s report published in 2017, in 2014, the number of drugs in development for cancer was 1,919.

Increasing number of drugs are being approved for treating various types of cancer. According to U.S. FDA, around 16 new drugs were approved in 2017 for treatment of cancer. Moreover, by mid November 2018, eight more drugs were approved for cancer. Notable drug approvals from 2017 include,

Get PDF Brochure of Research Report: https://www.coherentmarketinsights.com/insight/request-pdf/2332

Yescarta from Kite Pharmaceuticals that consist of the axicabtagene ciloleucel, for the treatment of relapsed or refractory large B-cell lymphomas (approved in October 2017)

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

About Us:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Oncology Drugs Market is growth 2019 | Novartis International AG, Celgene Corporation, Johnson & Johnson, Bristol-Myers Squibb, Pfizer Inc., Merck & Co., Eli Lilly and Company, AbbVie, Inc here

News-ID: 1837496 • Views:

More Releases from CMI Research

Complete guide to Eosinophilic Esophagitis Market 2023: Expanding due to immune system rapid growth | Ellodi Pharmaceuticals, EsoCap AG, GlaxoSmithKline
Complete guide to Eosinophilic Esophagitis Market 2023: Expanding due to immune …
Eosinophilic Esophagitis (EoE) is a chronic inflammatory condition of the esophagus. It is characterized by the accumulation of a type of white blood cells called eosinophils in the lining of the esophagus. EoE can cause a range of symptoms, including difficulty swallowing, food impaction, chest pain, and heartburn. Steroids are the primary treatment option for EoE. They help control inflammation and reduce the number of eosinophils in the esophagus. Topical steroids
A complete guide to Adoptive Cell Therapy Market 2023: growing demand for personalized medicine rapid growth | Gilead Sciences, Inc., Castle Creek Biosciences, Inc., Lineage Cell Therapeutics
A complete guide to Adoptive Cell Therapy Market 2023: growing demand for person …
Adoptive cell therapy (ACT) is a form of immunotherapy that involves the genetic modification of T cells to enhance their cancer-fighting capabilities. This treatment has shown promising results in the treatment of several types of cancer and is expected to become a major player in the oncology market in the coming years. The global adoptive cell therapy market size was valued at USD 1.12 billion in 2021 and is projected to
A complete guide to the TCV Vaccines Market 2023: market size, growth trends, key drivers and and future outlook 2030 | GlaxoSmithKline PLC, Sanofi SA, Bharat Biotech
A complete guide to the TCV Vaccines Market 2023: market size, growth trends, ke …
Conjugate vaccine (Vi-TT) consists of Vi antigen that is coupled to a carrier protein. In this vaccine, polysaccharide is attached to a more complex protein. In infants, these cells can effectively develop immune protection against pathogens. Polysaccharides are weaker by itself, however, by binding to a protein carrier, polysaccharides can enter into important parts of the immune system with ease and can get more easily noticed by the immunity system
A complete guide to Corporate Wellness Market 2023: Market size, growth trends, key drivers and challenges, and future outlook 2030 | Wellness Corporate Solutions, ComPsych Corporation, United Health Group
A complete guide to Corporate Wellness Market 2023: Market size, growth trends, …
The corporate wellness market has been gaining popularity over the years as more companies recognize the importance of keeping their employees healthy and productive. Corporate wellness programs are designed to improve the overall health and well-being of employees by providing them with resources and support to manage their physical and mental health. The corporate wellness market is expected to grow significantly from 2023-2030. According to a report by Coherent Market Insights,

All 5 Releases


More Releases for Oncology

Precision Oncology Market Top Companies Study - Laboratory Corporation of Americ …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Precision Oncology Market Size, Share & Trends Analysis Report By Product Type (Diagnostics, Therapeutics), By Cancer Type (Breast Cancer, Cervical Cancer, Prostate Cancer, Lung Cancer), By End-use (Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, and Healthcare Data Companies)- Market Outlook And Industry Analysis 2031" The global Precision Oncology market is estimated to reach over USD
Veterinary Oncology Market Report 2024 - Veterinary Oncology Market Size, Share …
"The Business Research Company recently released a comprehensive report on the Global Veterinary Oncology Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. According to The Business Research Company's, The veterinary oncology market size
Hepatocellular Carcinoma Pipeline 2024 | Can-Fite BioPharma, Sinocelltech, AVEO …
DelveInsight, "Hepatocellular Carcinoma Pipeline Insight 2024" report provides comprehensive insights about 90+ companies and 95+ pipeline drugs in Hepatocellular Carcinoma pipeline landscape. It covers the Hepatocellular Carcinoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Hepatocellular Carcinoma therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Key Takeaways from the Hepatocellular Carcinoma Pipeline
Oncology Clinical Trials Market: Collaboration and Innovation in Oncology Resear …
Allied Market Research analysts have recently conducted a comprehensive research study titled "Oncology Clinical Trials Market: Global Outlook and Forecast 2023-2030." The report provides detailed information and analysis on key players in the market, including PAREXEL International, PRA Health Sciences, Syneos Health, Medpace, Novotech, Pivotal, Novartis, Merck, Bristol Myers Squibb company, and F. Hoffmann-La Roche. The study offers an in-depth analysis that encompasses clear market definitions, classifications, manufacturing processes, cost
Hemato Oncology Testing Market Global Hemato Oncology Testing Market, Hemato Onc …
Global Hemato Oncology Testing Market Research report is an in-depth study of the market Analysis. Along with the most recent patterns and figures that uncovers a wide examination of the market offer. This report provides exhaustive coverage on geographical segmentation, latest demand scope, growth rate analysis with industry revenue and CAGR status. While emphasizing the key driving and restraining forces for this market, the report also offers a complete study
Oncology Market Size to Hit $447.3 Billion by 2028 | Oncology Industry Forecast …
Market Overview: According to our experience research team, Oncology Market was valued at USD 283.5 Billion in 2021, and the global Oncology industry is projected to reach a value of USD 447.3 Billion by 2028, at a CAGR of 7.9% during the forecast period 2022-2028 Vantage Market Research is a collection of market research studies on several industries, such as Chemicals, semiconductors & Electronics, Food & Beverages Technology, Energy & Power, Agriculture,